MedPath

江西金世康药业有限公司

Ownership
-
Established
2002-11-15
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

ORYZANOLUM

Product Name
谷维素片
Approval Number
国药准字H36021334
Approval Date
Apr 19, 2022
NMPA

天麻胶囊

Approval Number
国药准字Z22023770
Approval Date
Apr 28, 2020
NMPA

心脑欣片

Approval Number
国药准字Z20090371
Approval Date
Jun 24, 2019
NMPA

安胃止痛胶囊

Approval Number
国药准字Z20090825
Approval Date
May 30, 2019
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.